Table 1.
Patient characteristics (n = 49)
| Age (years) | 70 (61–82) |
| Tumor size (mm) | 22 (10–70) |
| Sex | |
| Male | 27 (55.1) |
| Female | 22 (44.9) |
| Primary tumor location | |
| Head/neck | 36 (73.5) |
| Body/tail | 13 (26.5) |
| Operation procedure | |
| Pancreatoduodenectomy | 34 (69.4) |
| Distal Pancreatectomy | 11 (22.4) |
| Total Pancreatectomy | 4 (8.2) |
| NCCN resectability (2015) | |
| Resectable | 41 (83.7) |
| Borderline resectable | |
| BR-PVa | 7 (14.3) |
| BR-Aa | 1 (2) |
| Operation time (min) | 477 (231–816) |
| Intraoperative bleeding (mL) | 1360 (231–9268) |
| Postoperative hospital stays (days) | 25 (14–152) |
| Complication after surgery | 12 (24.5) |
| Uncompleted adjuvant chemotherapy | 22 (44.9) |
Data are presented as median (range) or n (%). Each value was assessed before neoadjuvant chemoradiotherapy
NCCN, National Comprehensive Cancer Network; BR-PV, borderline resectable with portal vein invasion; BR-A, borderline resectable with arterial invasion
aAccording to NCCN guideline 2018 [1]